Učitavanje...
Acquired hemophilia A: emerging treatment options
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor) to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe, potentially life-threatening hemorrhage. Disease management focuses on controlling bleeding, primarily with the use...
Spremljeno u:
| Izdano u: | J Blood Med |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4431493/ https://ncbi.nlm.nih.gov/pubmed/26056504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S77332 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|